THERAPEUTIC FOCUS
RESEARCH & DEVELOPMENT
Shareholder Tools
Briefcase Printed Materials Email Alerts Download Center snapshot RSS

Press Releases

The press releases contained in this section of the website are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Amarin disavows any obligation to update the information contained in such press releases after the date of their issuance.

All Releases
View Summary Amarin Appoints Craig B. Granowitz Chief Medical Officer and Names Steven Ketchum Chief Scientific Officer
21 Jan 2016
PDF 71.1 KB Add to Briefcase
View Summary Amarin Reports Preliminary 2015 Net Product Sales and Provides 2016 Revenue and Business Outlook
11 Jan 2016
PDF 72.5 KB Add to Briefcase
View Summary Amarin Added to NASDAQ Biotechnology Index
14 Dec 2015
PDF 10.7 KB Add to Briefcase
View Summary Amarin to Present at the Oppenheimer & Co. Inc. 26th Annual Healthcare Conference
2 Dec 2015
PDF 10.5 KB Add to Briefcase
View Summary Amarin to Present at the 27th Annual Piper Jaffray Healthcare Conference
24 Nov 2015
PDF 10.5 KB Add to Briefcase
View Summary Amarin Announces Agreement to Purchase $16.2 Million of Its Existing Exchangeable Notes and Pricing of $31.3 Million of New Exchangeable Notes
20 Nov 2015
PDF 14.2 KB Add to Briefcase
View Summary EPA Therapy Added to Statin Therapy Showed Coronary Plaque Regression at Approximately Twice the Prevalence Compared to Statin Therapy Alone in Japanese Clinical Study
9 Nov 2015
PDF 66.1 KB Add to Briefcase
View Summary Amarin Reports Third Quarter 2015 Financial Results and Provides Update on Operations
4 Nov 2015
PDF 95.0 KB Add to Briefcase
View Summary Amarin to Report Third Quarter 2015 Results and Host Conference Call on November 4, 2015
28 Oct 2015
PDF 12.7 KB Add to Briefcase
View Summary Amarin to Present at the Rodman & Renshaw 2015 Global Investment Conference
2 Sep 2015
PDF 10.4 KB Add to Briefcase
View Summary Amarin Announces Encore Presentation of Results of the Apolipoprotein C-III Post-Hoc Analysis From MARINE and ANCHOR Studies of Vascepa(R) at the European Society of Cardiology (ESC) 2015 Annual Congress
27 Aug 2015
PDF 62.1 KB Add to Briefcase
View Summary Amarin Promotes Joseph T. Kennedy to Executive Vice President, General Counsel and Strategic Initiatives
11 Aug 2015
PDF 14.2 KB Add to Briefcase
View Summary First Amendment Decision a Win for Amarin and Physician Plaintiffs
7 Aug 2015
PDF 73.7 KB Add to Briefcase
View Summary Amarin Reports Second Quarter 2015 Financial Results and Provides Update on Operations
6 Aug 2015
PDF 94.7 KB Add to Briefcase
View Summary Amarin Announces Upcoming Presentations of Two Eicosapentaenoic Acid (EPA) Studies at the American Society for Preventive Cardiology (ASPC) Annual Cardiovascular Disease Prevention Conference and the Kern Lipid Conference
31 Jul 2015
PDF 62.8 KB Add to Briefcase
View Summary Amarin to Report Second Quarter 2015 Results and Host Conference Call on August 6, 2015
30 Jul 2015
PDF 12.1 KB Add to Briefcase
View Summary New In Vitro Eicosapentaenoic Acid Study Data to Be Presented at the National Lipid Association Scientific Sessions in Chicago
11 Jun 2015
PDF 12.3 KB Add to Briefcase
View Summary New In Vitro Eicosapentaenoic Acid Study Data Presented June 6 at the American Diabetes Association Scientific Sessions in Boston
8 Jun 2015
PDF 12.2 KB Add to Briefcase
View Summary Amarin Granted Summary Judgment Motion in Suit Against FDA Seeking New Chemical Entity Market Exclusivity for Vascepa(R) (Icosapent Ethyl) Capsules
28 May 2015
PDF 59.3 KB Add to Briefcase
View Summary Amarin to Present at the Jefferies 2015 Global Healthcare Conference
26 May 2015
PDF 10.3 KB Add to Briefcase
Showing 1-20 of 241 Page: 1 2 3 4 5 ... 13  Next 20
Add to Briefcase = add release to Briefcase